olsalazine has been researched along with uric acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, L; Kung, H; Leung, KS; Li, H; Li, L; Lin, H; Lin, MC; Niu, Y; Wong, MH; Xiong, W | 1 |
| Gao, L; Li, H; Li, L; Li, Q; Lin, H; Niu, Y; Yang, P | 1 |
2 other study(ies) available for olsalazine and uric acid
| Article | Year |
|---|---|
Old drug, new indication: Olsalazine sodium reduced serum uric acid levels in mice via inhibiting xanthine oxidoreductase activity.
Topics: Aminosalicylic Acids; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hyperuricemia; In Vitro Techniques; Male; Mice; Structure-Activity Relationship; Uric Acid; Xanthine Dehydrogenase | 2017 |
Olsalazine Sodium Increases Renal Urate Excretion by Modulating Urate Transporters in Hyperuricemic Animals.
Topics: Aminosalicylic Acids; Animals; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Dose-Response Relationship, Drug; Glucose Transport Proteins, Facilitative; Humans; Hyperuricemia; Kidney Tubules, Proximal; Male; Mice; Monosaccharide Transport Proteins; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Rats; Rats, Sprague-Dawley; Renal Elimination; Renal Reabsorption; Sodium-Phosphate Cotransporter Proteins, Type I; Uric Acid | 2020 |